On this page: About the National Data | Methodology | History
About the National Data
Data
Baseline: 46.2 percent of adults aged 18 years and over with diagnosed diabetes and chronic kidney disease received recommended medical treatment with ACE inhibitors or ARBs in 2013-16
Target: 58.6 percent
Methodology
Questions used to obtain the national baseline data
From the 2013-16 National Health and Nutrition Examination Survey:
Numerator and Denominator:
Other than during pregnancy, {Have you/Has SP} ever been told by a doctor or other health professional that {you have/{he/she/SP} has} diabetes or sugar diabetes?- YES
- NO
- Borderline or pre-diabetes
- Refused
- Don't know
Methodology notes
Chronic kidney disease (CKD) stages 1–4 defined as urinary albumin-to-creatinine ratio (ACR) ≥ 30 mg/g (single measurement) or eGFR between 15 and 59 ml/min/1.73 m². The eGFR was computed using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation. Single ACR measurement was used (all measurements in mg/g).
ACE/ARB use is obtained using the NHANES prescription drug files. Numerator and denominator are based on NHANES interview question and on NHANES Mobile Examination Center laboratory testing.
Age-adjustment notes
This Indicator uses Age-Adjustment Groups:
- Total: 18-44, 45-64, 65+
- Sex: 18-44, 45-64, 65+
- Race/Ethnicity: 18-44, 45-64, 65+
- Educational Attainment: 25-44, 45-64, 65+
- Family Income (percent poverty threshold): 18-44, 45-64, 65+
- Country of Birth: 18-44, 45-64, 65+
- Disability Status: 20-44, 45-64, 65+
- Health Insurance Status: 18-44, 45-64
- Marital Status: 20-44, 45-64, 65+
- Veteran Status: 18-44, 45-64, 65+
- Obesity Status: 20-44, 45-64, 65+
History
In 2023, the original baseline was revised from 43.0 to 46.2 percent due to changes to 2021 race free, serum creatine only CKD-EPI equation used to determine estimated glomerular filtration rate (eGFR). The target was adjusted from 55.4 to 58.6 percent to reflect the revised baseline using the original target-setting method.